These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23831857)

  • 1. Mathematical modeling in cancer drug discovery.
    Wang Z; Deisboeck TS
    Drug Discov Today; 2014 Feb; 19(2):145-50. PubMed ID: 23831857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current mathematical models for cancer drug discovery.
    Carrara L; Lavezzi SM; Borella E; De Nicolao G; Magni P; Poggesi I
    Expert Opin Drug Discov; 2017 Aug; 12(8):785-799. PubMed ID: 28595492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical modeling for novel cancer drug discovery and development.
    Zhang P; Brusic V
    Expert Opin Drug Discov; 2014 Oct; 9(10):1133-50. PubMed ID: 25062617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational modeling in melanoma for novel drug discovery.
    Pennisi M; Russo G; Di Salvatore V; Candido S; Libra M; Pappalardo F
    Expert Opin Drug Discov; 2016 Jun; 11(6):609-21. PubMed ID: 27046143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mathematical modeling of efficacy and safety for anticancer drugs clinical development.
    Lavezzi SM; Borella E; Carrara L; De Nicolao G; Magni P; Poggesi I
    Expert Opin Drug Discov; 2018 Jan; 13(1):5-21. PubMed ID: 28972401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: challenges and opportunities.
    Venkatakrishnan K; Friberg LE; Ouellet D; Mettetal JT; Stein A; Trocóniz IF; Bruno R; Mehrotra N; Gobburu J; Mould DR
    Clin Pharmacol Ther; 2015 Jan; 97(1):37-54. PubMed ID: 25670382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted approaches to childhood cancer: progress in drug discovery and development.
    Hirsch S; Marshall LV; Carceller Lechon F; Pearson AD; Moreno L
    Expert Opin Drug Discov; 2015 May; 10(5):483-95. PubMed ID: 25840490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel drugs for promising targets.
    Martell RE; Brooks DG; Wang Y; Wilcoxen K
    Clin Ther; 2013 Sep; 35(9):1271-81. PubMed ID: 24054704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancing cancer drug discovery towards more agile development of targeted combination therapies.
    Carragher NO; Unciti-Broceta A; Cameron DA
    Future Med Chem; 2012 Jan; 4(1):87-105. PubMed ID: 22168166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Big data' approaches for novel anti-cancer drug discovery.
    Benstead-Hume G; Wooller SK; Pearl FMG
    Expert Opin Drug Discov; 2017 Jun; 12(6):599-609. PubMed ID: 28462602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-engineered 3D tumor angiogenesis models: potential technologies for anti-cancer drug discovery.
    Chwalek K; Bray LJ; Werner C
    Adv Drug Deliv Rev; 2014 Dec; 79-80():30-9. PubMed ID: 24819220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The path to oncology drug target validation: an industry perspective.
    Cortés-Cros M; Schmelzle T; Stucke VM; Hofmann F
    Methods Mol Biol; 2013; 986():3-13. PubMed ID: 23436402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serendipity in Cancer Drug Discovery: Rational or Coincidence?
    Prasad S; Gupta SC; Aggarwal BB
    Trends Pharmacol Sci; 2016 Jun; 37(6):435-450. PubMed ID: 27083322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-targeted hybrids based on HDAC inhibitors for anti-cancer drug discovery.
    Seo SY
    Arch Pharm Res; 2012 Feb; 35(2):197-200. PubMed ID: 22370774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse tumour models to guide drug development and identify resistance mechanisms.
    Das Thakur M; Pryer NK; Singh M
    J Pathol; 2014 Jan; 232(2):103-11. PubMed ID: 24122209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network pharmacology for cancer drug discovery: are we there yet?
    Azmi AS
    Future Med Chem; 2012 May; 4(8):939-41. PubMed ID: 22650234
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of Antineoplastic Targets with Systems Approaches, Using Resveratrol as an In-Depth Case Study.
    Singh N; Freiesleben S; Wolkenhauer O; Shukla Y; Gupta SK
    Curr Pharm Des; 2017; 23(32):4773-4793. PubMed ID: 28699531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer drug discovery: recent innovative approaches to tumor modeling.
    Lovitt CJ; Shelper TB; Avery VM
    Expert Opin Drug Discov; 2016 Sep; 11(9):885-94. PubMed ID: 27454169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A snapshot of challenges and solutions in cancer drug development and therapy.
    Phelps MA; Sparreboom A
    Clin Pharmacol Ther; 2014 Apr; 95(4):341-6. PubMed ID: 24646480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.